Image pharmaphorum Editor Views & Analysis What will the digital health ecosystem look like post-COVID? COVID-19 has turned the world on its head and healthcare systems have had to respond rapidly to match the sudden changes created by lockdown. Views & Analysis Navigating the NHS as a digital start-up We speak to finalists from the Greater Manchester Future of Health accelerator to find out how digital start-ups can overcome the challenges small companies face in bringing their technolog Views & Analysis A pivotal moment for digital health adoption Former chief digital officer for the NHS, Juliet Bauer, is now applying her experience to the private sector through video consultation firm Livi. Views & Analysis A new dawn for clinical trial management It’s time for pharma to take a 360-degree view of its clinical trial data and step into the future with near real-time trial management. Load more results
Views & Analysis What will the digital health ecosystem look like post-COVID? COVID-19 has turned the world on its head and healthcare systems have had to respond rapidly to match the sudden changes created by lockdown.
Views & Analysis Navigating the NHS as a digital start-up We speak to finalists from the Greater Manchester Future of Health accelerator to find out how digital start-ups can overcome the challenges small companies face in bringing their technolog
Views & Analysis A pivotal moment for digital health adoption Former chief digital officer for the NHS, Juliet Bauer, is now applying her experience to the private sector through video consultation firm Livi.
Views & Analysis A new dawn for clinical trial management It’s time for pharma to take a 360-degree view of its clinical trial data and step into the future with near real-time trial management.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
